Nikhil Wagle, MD

Nikhil Wagle, MD, is an assistant professor of medicine at Harvard Medical School, a medical oncologist at Dana-Farber Cancer Institute, and an Institute Member of the Broad Institute of Massachusetts Institute of Technology and Harvard University.

Dr. Wagle leads a translational research program in cancer genomics and cancer precision medicine, with a particular focus on metastatic breast cancer. The major goals of his work are to better understand the biology of cancer and to develop new ways to overcome or prevent drug resistance in patients with advanced cancer. Ultimately, his research aims to develop new therapeutic strategies and to identify characteristics of tumors that might improve clinical decision-making for patients.

He is also the President and Director of the Count Me In, a nonprofit research initiative that aims to transform cancer care by empowering cancer patients to accelerate cancer research by sharing their samples, their medical information, and their voices.  The program’s first project, The Metastatic Breast Cancer Project, is a nationwide patient-driven research initiative that engages patients with advanced breast cancer across the U.S. and Canada through social media and seeks to empower them to accelerate cancer research through sharing their samples and clinical information. Additional projects for patients with angiosarcoma, metastatic prostate cancer, esophageal and stomach cancer, brain cancer, osteosarcoma, leiomyosarcoma, and colorectal cancer have also been launched.

Dr. Wagle also co-founded Doctors for America, a grassroots organization of over 18,000 doctors and medical students in the United States who are working to build a better health care system for all Americans.

It was really my experience as a medical resident and oncology fellow. Taking care of patients with metastatic breast cancer and knowing we hadn’t yet found a way to cure this disease led me to want to devote my research career to this. I worked with many breast cancer patients, but when someone had metastatic breast cancer – there was a whole different approach to working with them. It was incredibly frustrating to not be able to offer people treatments that would cure their cancer.”
– Dr. Nikhil Wagle, The Cancer Couch

Expertise

  • Breast oncology
  • Cancer genomics
  • Precision cancer medicine
  • Therapeutic resistance
  • Patient-partnered research

Education

Experience

Awards and distinctions

Professional memberships and board positions

Publications

In the media

Connect on social media

Learn more about Dr. Wagle on Dana Farber’s website.

Contributions